Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?
作者： Robert E. Becker , Nigel H. Greig , Ezio Giacobini
关键词: Research design 、 Clinical trial 、 Neuropathology 、 Disease 、 Psychiatry 、 Human error 、 Intensive care medicine 、 Alzheimer's disease 、 Medicine 、 Variance (accounting) 、 MEDLINE
摘要: … disease (AD) drug developments and CTs … drug developments at present, for the current article we reviewed the literature that we could find with potential relevance for AD CT and drug …
sci-hub.se 参考文章(138)
Pincus T, Stein Cm, Why randomized controlled clinical trials do not depict accurately long-term outcomes in rheumatoid arthritis: some explanations and suggestions for future studies. Clinical and Experimental Rheumatology. ,vol. 15, ,(1997)
Robert E. Becker, Focusing pharmaceutical research on patient care: Using clinical trials to develop clinical decision rules Clinical Drug Investigation. ,vol. 22, pp. 269- 278 ,(2002) , 10.2165/00044011-200222050-00001
Robert E. Becker, Therapy of the Cognitive Deficit in Alzheimer’s Disease: The Cholinergic System Cholinergic Basis for Alzheimer Therapy. pp. 1- 22 ,(1991) , 10.1007/978-1-4899-6738-1_1
Christopher B. Granger, John J.V. McMurray, Using measures of disease progression to determine therapeutic effect: a sirens' song. Journal of the American College of Cardiology. ,vol. 48, pp. 434- 437 ,(2006) , 10.1016/J.JACC.2006.03.050
ADAPT Research Group, None, Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology. ,vol. 68, pp. 1800- 1808 ,(2007) , 10.1212/01.WNL.0000260269.93245.D2
Ezio Giacobini, Robert E. Becker, Cholinergic Basis for Alzheimer Therapy ,(1991)
Ezio Giacobini, Robert E. Becker, One Hundred Years after the Discovery of Alzheimer's Disease. A Turning Point for Therapy? Journal of Alzheimer's Disease. ,vol. 12, pp. 37- 52 ,(2007) , 10.3233/JAD-2007-12105
Yardley Beers, Introduction to the theory of error ,(1953)
Jeffrey L. Cummings, Clinical evaluation as a biomarker for Alzheimer's disease. Journal of Alzheimer's Disease. ,vol. 8, pp. 327- 337 ,(2006) , 10.3233/JAD-2005-8402
W. Jagust, R. Thisted, M.D. Devous, R. Van Heertum, H. Mayberg, K. Jobst, A.D. Smith, N. Borys, SPECT perfusion imaging in the diagnosis of Alzheimer’s disease: A clinical-pathologic study Neurology. ,vol. 56, pp. 950- 956 ,(2001) , 10.1212/WNL.56.7.950